As CCA cells use EVs to interact with surrounding mesenchymal stem cells to modulate the microenvironment and enhance the tumor growth [78], it can be postulated that the reduction of these cell interactions via CD24 and CD44 loaded EVs after SIRT may reduce tumor growth and progression. This evidence concerns the gene CD44 and cholangiocarcinoma.